Please login to the form below
Henrik Stenqvist joins Recipharm
Was previously CFO for Meda Group
Recipharm appoints Henrik Stenqvist as its new executive VP and chief financial officer, bringing 24 years of finance and management experience.
He said: “I’m looking forward to contributing to the continued success of Recipharm in my new capacity as chief financial officer of this leading company.”
Prior to joining Recipharm, Stenqvist served as CFO for Meda Group and has held other finance positions in the pharmaceutical industry.
Thomas Eldered, CEO of Recipharm, said: “I am very pleased to welcome Henrik, his extensive experience and perspectives in finance, business and strategic development in the pharmaceutical industry make him a great fit for Recipharm as we continue on our strong growth path.”
Stenqvist will be based at the company’s headquarters in Stockholm, Sweden where he will focus on financial planning and reporting.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Lead Copywriter
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Medical Editor
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Account Director
-
Competitive
- PHE study finds people who have had COVID-19 can still transmit the virus
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Nucleus Global announces a trio of promotions
- PHE study finds people who have had COVID-19 can still transmit the virus
- AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine
- Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
- Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%
- Gilead’s Jyseleca is given a NICE recommendation for rheumatoid arthritis
- Janet Woodcock named acting commissioner of the FDA
- Lateral flow tests detect ‘most infectious’ COVID-19 cases, Oxford researchers find
- 3 reasons why clinical trials will thrive in 2021
- #DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
PMHub
McCann Health Medical Communications
We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....
Latest intelligence
- 3 reasons why clinical trials will thrive in 2021
- It’s not often that a single event can change the trajectory of an entire system, yet that is exactly what has happened to healthcare systems across the world and clinical...
- #DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
- Lack of diversity in clinical trials still remains on of the biggest issues for COVID-19 clinical trials. But despite the growing discussions, calls for change, growing regulatory guidance and much...
- The pandemic preparedness paradox
- Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Quick links
Infographics
